JP2019516684A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516684A5
JP2019516684A5 JP2018557837A JP2018557837A JP2019516684A5 JP 2019516684 A5 JP2019516684 A5 JP 2019516684A5 JP 2018557837 A JP2018557837 A JP 2018557837A JP 2018557837 A JP2018557837 A JP 2018557837A JP 2019516684 A5 JP2019516684 A5 JP 2019516684A5
Authority
JP
Japan
Prior art keywords
compound
day
weight
pharmaceutically acceptable
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018557837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019516684A (ja
JP7145080B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/031142 external-priority patent/WO2017192905A1/en
Publication of JP2019516684A publication Critical patent/JP2019516684A/ja
Publication of JP2019516684A5 publication Critical patent/JP2019516684A5/ja
Priority to JP2022147751A priority Critical patent/JP7586868B2/ja
Application granted granted Critical
Publication of JP7145080B2 publication Critical patent/JP7145080B2/ja
Priority to JP2024195175A priority patent/JP2025026895A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018557837A 2016-05-04 2017-05-04 重水素化jak阻害剤による脱毛障害の処置 Active JP7145080B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022147751A JP7586868B2 (ja) 2016-05-04 2022-09-16 重水素化jak阻害剤による脱毛障害の処置
JP2024195175A JP2025026895A (ja) 2016-05-04 2024-11-07 重水素化jak阻害剤による脱毛障害の処置

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201662331827P 2016-05-04 2016-05-04
US62/331,827 2016-05-04
US201662338869P 2016-05-19 2016-05-19
US62/338,869 2016-05-19
US201662418774P 2016-11-07 2016-11-07
US62/418,774 2016-11-07
US201662419237P 2016-11-08 2016-11-08
US62/419,237 2016-11-08
US201662434404P 2016-12-14 2016-12-14
US62/434,404 2016-12-14
US201762466358P 2017-03-02 2017-03-02
US62/466,358 2017-03-02
US201762492758P 2017-05-01 2017-05-01
US62/492,758 2017-05-01
PCT/US2017/031142 WO2017192905A1 (en) 2016-05-04 2017-05-04 Treatment of hair loss disorders with deuterated jak inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022147751A Division JP7586868B2 (ja) 2016-05-04 2022-09-16 重水素化jak阻害剤による脱毛障害の処置

Publications (3)

Publication Number Publication Date
JP2019516684A JP2019516684A (ja) 2019-06-20
JP2019516684A5 true JP2019516684A5 (enExample) 2020-06-18
JP7145080B2 JP7145080B2 (ja) 2022-09-30

Family

ID=60203616

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018557837A Active JP7145080B2 (ja) 2016-05-04 2017-05-04 重水素化jak阻害剤による脱毛障害の処置
JP2022147751A Active JP7586868B2 (ja) 2016-05-04 2022-09-16 重水素化jak阻害剤による脱毛障害の処置
JP2024195175A Pending JP2025026895A (ja) 2016-05-04 2024-11-07 重水素化jak阻害剤による脱毛障害の処置

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022147751A Active JP7586868B2 (ja) 2016-05-04 2022-09-16 重水素化jak阻害剤による脱毛障害の処置
JP2024195175A Pending JP2025026895A (ja) 2016-05-04 2024-11-07 重水素化jak阻害剤による脱毛障害の処置

Country Status (21)

Country Link
US (3) US10561659B2 (enExample)
EP (2) EP3452039B1 (enExample)
JP (3) JP7145080B2 (enExample)
KR (3) KR102810262B1 (enExample)
CN (1) CN109069493A (enExample)
AU (3) AU2017261286B2 (enExample)
BR (1) BR112018072339A2 (enExample)
CA (1) CA3022519A1 (enExample)
DK (1) DK3452039T3 (enExample)
ES (1) ES2988629T3 (enExample)
FI (1) FI3452039T3 (enExample)
HR (1) HRP20241345T1 (enExample)
HU (1) HUE068643T2 (enExample)
LT (1) LT3452039T (enExample)
MX (6) MX388054B (enExample)
PL (1) PL3452039T3 (enExample)
PT (1) PT3452039T (enExample)
RS (1) RS66006B1 (enExample)
SI (1) SI3452039T1 (enExample)
SM (1) SMT202400389T1 (enExample)
WO (1) WO2017192905A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3022519A1 (en) * 2016-05-04 2017-11-09 Concert Pharmaceuticals, Inc. Treatment of hair loss disorders with deuterated jak inhibitors
CA3129096A1 (en) * 2019-02-06 2020-08-13 Concert Pharmaceuticals, Inc. Process for preparing enantiomerically enriched jak inhibitors
WO2021236139A1 (en) 2020-05-21 2021-11-25 Concert Pharmaceuticals, Inc. Novel deuterated jak inhibitor and uses thereof
CN116916927A (zh) * 2020-10-28 2023-10-20 太阳医药工业公司 用于用氘化jak抑制剂治疗脱发症的方案
CA3196551A1 (en) * 2020-10-28 2022-05-05 Sun Pharmaceutical Industries, Inc. Regimens for the treatment of hair loss disorders with deuterated jak inhibitors
CN112402615A (zh) * 2020-11-11 2021-02-26 长沙晶易医药科技有限公司 一种用于治疗斑秃的复方外用制剂及其制备方法
EP4384175A1 (en) 2021-08-11 2024-06-19 Sun Pharmaceutical Industries, Inc. Treatment of hair loss disorders with deuterated jak inhibitors
WO2023018954A1 (en) 2021-08-12 2023-02-16 Concert Pharmaceuticals, Inc. Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors
CA3250876A1 (en) 2022-05-04 2023-11-09 Sun Pharmaceutical Ind Inc DOSAGE REGIMEN FOR TREATMENT WITH DEUTERATED JAK INHIBITORS
US12364699B2 (en) * 2023-10-10 2025-07-22 Sun Pharmaceuticals Industries, Inc. Method of treating hair loss disorders
US12247034B1 (en) 2024-04-19 2025-03-11 Sun Pharmaceutical Industries, Inc. Crystalline form of deuruxolitinib phosphate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925962D0 (en) 1999-11-02 1999-12-29 Novartis Ag Organic compounds
HRP20030873B1 (en) 2001-05-03 2006-04-30 F. Hoffmann - La Roche Ag Pharmaceutical dosage form of amorphous nelfinavir mesylate
JP2008514706A (ja) 2004-09-29 2008-05-08 コーディス・コーポレイション 安定非晶質ラパマイシン様化合物の薬学的投与形態
DK3184526T3 (en) 2005-12-13 2019-01-14 Incyte Holdings Corp PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR
AU2006332726B2 (en) 2005-12-28 2012-12-13 Vertex Pharmaceuticals Incorporated. Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
CL2008001709A1 (es) 2007-06-13 2008-11-03 Incyte Corp Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
JOP20190231A1 (ar) 2009-01-15 2017-06-16 Incyte Corp طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
US9198911B2 (en) 2010-11-02 2015-12-01 The Trustees Of Columbia University In The City Of New York Methods for treating hair loss disorders
CN103370076A (zh) * 2010-11-02 2013-10-23 纽约市哥伦比亚大学托管会 治疗毛发脱落疾病的方法
CN104334191A (zh) 2012-03-29 2015-02-04 纽约市哥伦比亚大学托管会 治疗毛发脱落疾病的方法
CA2876306C (en) * 2012-06-15 2024-02-20 Concert Pharmaceuticals, Inc. Deuterated derivatives of ruxolitinib
CA2879400A1 (en) * 2012-07-30 2014-02-06 Concert Pharmaceuticals, Inc. Deuterated ibrutinib
PE20151157A1 (es) 2012-11-15 2015-08-19 Incyte Corp Formas de dosificacion de ruxolitinib de liberacion sostenida
JP6367545B2 (ja) * 2013-12-17 2018-08-01 コンサート ファーマシューティカルズ インコーポレイテッド ルキソリチニブの重水素化誘導体
CN104725380B (zh) * 2013-12-18 2019-06-28 康塞特医药品有限公司 卢索替尼的氘代衍生物
EA201691582A1 (ru) 2014-02-07 2017-01-30 Оспекс Фармасьютикалз, Инк. Новые фармацевтические препараты
CA3022519A1 (en) 2016-05-04 2017-11-09 Concert Pharmaceuticals, Inc. Treatment of hair loss disorders with deuterated jak inhibitors

Similar Documents

Publication Publication Date Title
JP2019516684A5 (enExample)
JP2018534348A5 (enExample)
RU2018114447A (ru) Введение дейтерированных усилителей cftr
HRP20241345T1 (hr) Liječenje poremećaja gubitka kose deuteriranim inhibitorima jak
JP2013507415A5 (enExample)
JP2009514874A5 (enExample)
JP2019503365A5 (enExample)
CN101678035A (zh) 用于治疗糖尿病的选择性雄激素受体调节剂
JP2020097577A5 (enExample)
JP2019517587A5 (enExample)
WO2011160136A3 (en) Progesterone containing oral dosage forms and related methods
JP2013529665A5 (enExample)
JP2013545752A5 (enExample)
JP2016515628A5 (enExample)
RU2017112308A (ru) Композиции и способы для лечения бессонницы
JP2013532729A5 (enExample)
TW201822769A (zh) 用於治療非小細胞肺癌之egfr t790m 抑制劑及cdk抑制劑之組合
JP2018090566A5 (enExample)
JP2012502103A5 (enExample)
JP2013519705A5 (enExample)
JP2021509395A5 (enExample)
JP2014521641A5 (enExample)
HRP20170564T1 (hr) Derivati aminociklobutana, metoda njihove priprave i njihova upotreba za lijekove
JP2020510027A5 (enExample)
CN105358149A (zh) 粉防己碱家族的药物制剂和方法